Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Sernova Investor Relations
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Post by Treeshon Mar 26, 2021 3:07pm
358 Views
Post# 32887817

Sernova Investor Relations

Sernova Investor Relations Just received this. . . anyone else?

Hi ,
 
Thank you for attending Sernova’s Investor Conference Call last on Thursday March 18, 2021. We had a lot of questions for Dr. Toleikis that unfortunately he did not get to. Were you able to get all the information you needed from the call? I also wanted to reach out to see if you had any follow-up questions.

Being in-house, I can coordinate any intros or provide you with any information for Sernova.
I would also like to invite you to join our mailing list at https://www.sernova.com/email-alerts/ to receive all the latest news.

Once again, thank you for your interest in Sernova and for attending our conference call.
 
Dominic Gray
Corporate Communications
Sernova Corp.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities